No Data
No Data
Brokers Name 2 Strong ASX 200 Shares to Buy Now
Chilwa Minerals Expects Separation Lab in Malawi to Be Fully Operational in Four Weeks
While Institutions Own 41% of ALS Limited (ASX:ALQ), Individual Investors Are Its Largest Shareholders With 56% Ownership
ALS Geochemistry Business Volumes Deteriorating, But Life Sciences Unit Remains Resilient, Says Jarden Research
Jarden Research Adjusts ALS' Price Target to AU$14.20 From AU$14.90; Keeps at Overweight
Goldman Sachs Says This ASX 100 Stock Is a Buy
No Data
No Data